Briacell Therapeutics Corp. (BCTX)
NASDAQ · Manufacturing · Pharmaceutical preparations
BCTX price, last 12 months
Key stats
- Previous close
- $3.28
- Open
- $3.29
- Day range
- $3.15 – $3.30
- 52-week range
- $2.60 – $13.09
- Volume
- 63.9K
- Avg volume (20 days)
- 67.4K
- Market cap
- $29.6M
Performance
Technicals and fundamentals
About Briacell Therapeutics Corp.
BriaCell Therapeutics Corp is a clinical-stage biotechnology company developing targeted immunotherapies to transform cancer care. Its Bria-IMT targeted immunotherapy is being developed in combination with the immune checkpoint inhibitor Retifanlimab in a pivotal Phase 3 study in metastatic breast cancer. The Company's operations focus on the research and development of its immunotherapy product candidates and related supporting activities.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $29.6M